Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

(2018) Philip M Bath et al.   LANCET

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

(2018) S. Claiborne Johnston et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients

(2017) Feng-Tong Zuo et al.   MEDICINE

Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial

(2017) Ying Zhao et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke

(2016) Tabassome Simon et al.   CIRCULATION

Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic AttackClinical Perspective

(2016) Yuesong Pan et al.   CIRCULATION

Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR

(2016) D. Edmund Anstey et al.   CLINICAL CARDIOLOGY

Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis

(2016) F. Ge et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials

(2016) Peter M Rothwell et al.   LANCET

Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke

(2016) Keun-Sik Hong et al.   STROKE

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis

(2016) Peng-Peng Niu et al.   BMJ Open

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial

(2016) David Wang et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) TrialCLINICAL PERSPECTIVE

(2015) Yilong Wang et al.   CIRCULATION

Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients

(2015) Xingyang Yi et al.   Journal of Clinical Neurology

Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke

(2015) Fan He et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Clopidogrel Plus Aspirin Prevents Early Neurologic Deterioration and Improves 6-Month Outcome in Patients With Acute Large Artery Atherosclerosis Stroke

(2014) Chun Wang et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

A Comparative Study of Dual versus Monoantiplatelet Therapy in Patients with Acute Large-Artery Atherosclerosis Stroke

(2014) Xingyang Yi et al.   Journal of Stroke & Cerebrovascular Diseases

Dual Antiplatelets Reduce Microembolic Signals in Patients with Transient Ischemic Attack and Minor Stroke: Subgroup Analysis of CLAIR Study

(2013) Alexander Y. Lau et al.   International Journal of Stroke

The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials

(2013) Xia Li et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

(2013) Yongjun Wang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack

(2012) Chamila M. Geeganage et al.   STROKE

Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial

(2011) Graeme J. Hankey et al.   International Journal of Stroke

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

(2010) Ka Sing Lawrence Wong et al.   LANCET NEUROLOGY

Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke

(2009) C. Bal dit Sollier et al.   CEREBROVASCULAR DISEASES

Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial

(2008) Victor L. Serebruany et al.   CLINICAL THERAPEUTICS

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility

(2008) Nikola Sprigg et al.   PLoS One